This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Luxembourg Institute of Science and Technology. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sylvain Legay: Innovator in Antiparasitic Treatments
Introduction
Sylvain Legay is a notable inventor based in Metz, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for parasitic diseases. His innovative work focuses on utilizing plant cell cultures to produce effective compounds for medical applications.
Latest Patents
Sylvain Legay holds a patent for a method of producing a composition that includes a 3-O-p-coumaroyl ester of tormentic acid derived from plant cell cultures. This invention is particularly relevant for its applications as an antiparasitic agent in the treatment of trypanosomiasis. The patent outlines a process for creating a (poly)hydroxylated pentacyclic triterpene composition, which can be used in pharmaceutical formulations aimed at preventing and treating this disease.
Career Highlights
Legay is affiliated with the Luxembourg Institute of Science and Technology, where he conducts research and development in the field of biotechnology. His work has led to advancements in the understanding and treatment of parasitic infections, showcasing his commitment to improving public health through innovative solutions.
Collaborations
Some of his notable coworkers include Christelle Andre and Joelle Leclercq. Their collaborative efforts contribute to the ongoing research and development initiatives at the Luxembourg Institute of Science and Technology.
Conclusion
Sylvain Legay's contributions to the field of pharmaceuticals, particularly in the development of antiparasitic treatments, highlight the importance of innovation in addressing global health challenges. His work exemplifies the potential of plant-based solutions in modern medicine.